China Factory for Cellulose In Tablets - China Diltiazem supplier manufacturer Diltiazem hcl CAS NO: 42399-41-7 – Guanlang Detail:
China Diltiazem supplier manufacturer Diltiazem hcl Cas 42399-41-7,we are one of the leading Diltiazem hcl suppliers manufacturers factory in china, if you want to buy Diltiazem hcl china,feel free to contact us for free sample and competitive price
Diltiazem TDS
Appearance | white powder |
Assay | 99% min |
Density | 1.26 g/cm3 |
Boiling point | 594.4ºC at 760 mmHg |
Melting point | 212 °C |
Flash point | 313.3ºC |
Storage condition | Seal and store in a dry place |
Diltiazem Pharmacology and toxicology:
1.This product is a non-dihydropyridine calcium channel blocker. Its effect is related to the inhibition of calcium influx during depolarizing of myocardium and vascular smooth muscle.
2.This product can effectively dilate the epicardial and subendocardial coronary arteries, relieve spontaneous angina or angina caused by ergoxin induced coronary artery spasm; Reduces myocardial oxygen demand, increases exercise tolerance, and relieves exertional angina by slowing the heart rate and lowering blood pressure.
3.This product relaxes the vascular smooth muscle, decreases the peripheral vascular resistance and lowers the blood pressure. The extent of hypotension is related to the degree of hypertension, and the normal blood pressure only makes the blood pressure drop slightly.
4.This product has negative inotropic effect and can slow down the conduction of sinoatrial node and atrioventricular node.
Diltiazem Usage
This product is a calcium channel blocker, which can relieve angina pectoris, reduce blood pressure, have negative inotropic effect, and slow down the conduction of sinoatrial node and atrioventricular node.
Diltiazem is a new type of calcium antagonist, which can be used to treat supraventricular dysrhythmia, angina pectoris and hypertension in the elderly.
Used for treatment of hypertensive Patients.
Diltiazem Contraindication:
1.Allergic to Diltiazem or other calcium channel blockers.
2.Severe hypotension or cardiogenic shock.
3.Acute myocardial infarction with pulmonary congestion.
4.Contraindicated in pregnancy
Diltiazem Adverse reaction:
Common: edema, headache, nausea, dizziness, rash, weakness
Diltiazem Packaging and Shipping:
Packaging: 1kg/Aluminum Foil Bag, 25kg/drum
Shipping: 7-15 days for big orders
Diltiazem Sample order
Available
About us:
Exhibition:
Company Certificate:
Shipping:
Product detail pictures:
Related Product Guide:
Cooperation
Our well-equipped facilities and great good quality regulate throughout all stages of manufacturing enables us to guarantee total buyer gratification for China Factory for Cellulose In Tablets - China Diltiazem supplier manufacturer Diltiazem hcl CAS NO: 42399-41-7 – Guanlang, The product will supply to all over the world, such as: Florida, Mauritius, Jersey, Our company has built stable business relationships with many well-known domestic companies as well as oversea customers. With the goal of providing high quality products to customers at low cots, we've been committed to improving its capacities in research, development, manufacturing and management. We have honored to receive recognition from our customers. Till now we have now passed ISO9001 in 2005 and ISO/TS16949 in 2008. Enterprises of "quality of survival, the credibility of development" for the purpose, sincerely welcome domestic and foreign businessmen to visit to discuss cooperation.
Hebei Guanlang Biotechnology Co., Ltd. belongs to Guanlang Group, which was founded in 2007 , located in Shijiazhuang city which is the capital of Hebei Province and hub sector among Beijing Tianjin and Hebei and has advantage of convenient transportation . Our company is a modern high-tech chemical enterprise with Research & Development, production and sales.We have our own factory and lab,also offer customized synthesis service for our customers.
By Camille from Botswana - 2017.09.28 18:29
The product manager is a very hot and professional person, we have a pleasant conversation, and finally we reached a consensus agreement.
By Michelle from Hungary - 2017.06.22 12:49